RENIAL
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22
Tablets №30.
The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.
In case of any discrepancies, please contact us at tel. +380 44 490 75 22
-
Adding to standard treatment with the use of beta-blocker with the purpose of decline of risk of the morbidity and death rate, related to the cardiovascular diseases, for stable patients with disfunction of the left ventricle (faction of the troop landing of the left ventricle ≤40%) and the clinical signs of heart failure after the recently carried heart attack of myocardium. Adding to standard optimal therapy with the purpose of decline of risk of morbidity and death rate related to the cardiovascular diseases, for adult patients with the heart failure of II of class (chronic) on classification of NYHA and disfunction of the left ventricle (faction of the troop landing of the left ventricle ≤30%).
-
1 tablet contains eplerenone in terms of 100% of the substance 25 mg or 50 mg.
